Cargando…
381 Perspective of psoriatic disease patients on novel COVID-19 vaccines
Autores principales: | Gondo, G., Heydon, S., Bell, S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053922/ http://dx.doi.org/10.1016/j.jid.2021.02.403 |
Ejemplares similares
-
338 Clinical outcomes in COVID-19 patients with dermatopolymyositis
por: Pakhchanian, H., et al.
Publicado: (2021) -
336 Risks of COVID-19 infection and mortality for patients on biologics
por: Pahalyants, V., et al.
Publicado: (2021) -
342 Clinical outcomes in COVID-19 patients with Atopic dermatitis
por: Pakhchanian, H., et al.
Publicado: (2021) -
254 COVID-19 related outcomes in psoriasis and psoriasis arthritis patients
por: Raiker, R., et al.
Publicado: (2021) -
243 Clinical outcomes in COVID-19 patients with varicella zoster virus
por: Raiker, R., et al.
Publicado: (2021)